Introduction: Proton therapy is an advanced radiotherapy treatment that utilizes accelerated protons up to 250 MeV to target tumours. It is a highly demanding treatment modality that requires precise delivery of protons in a safe and accurate manner. Proton therapy offers favourable physical characteristics compared to conventional radiotherapy, as protons penetrate tissues to a precise depth, called the Bragg peak, where they deposit the majority of their energy. This results in lower doses to surrounding, healthy tissues, reducing toxicity and side effects. Moreover, proton therapy exhibits biological advantages, delivering a 10% higher biological effect than conventional therapy at the same dose. There are ongoing clinical trials. Currently, proton therapy is primarily used to treat paediatric patients, ocular melanomas, brain, and skull base tumours. While constructing a proton centre is complex and expensive, increasing competitiveness in the market is making it more affordable to us. Purpose: This master's thesis aims to introduce proton therapy as an advanced form of radiotherapy to radiographers and other healthcare professionals, as knowledge on this subject in Slovenia is limited to a small group of professionals. Methods: The literature review was conducted from 2019 until the completion of this master's thesis. We focused on English and Slovenian literature, obtained from Google Scholar, DiKUL, ScienceDirect and PubMed databases, as well as books and other relevant sources. Additionally, we complemented our findings by visiting two nearby proton centres, actively observing and engaging with their team. Discussion and conclusion: The demand for oncology treatment is increasing due to the rising incidence of cancer worldwide. Alongside successful treatment outcomes, there is a growing emphasis on reducing side effects and improving patients' quality of life. Proton therapy holds tremendous potential in the field of radiotherapy. Establishing a proton centre in Slovenia would ensure the highest level of cancer treatment for our patients. The Proton Therapy Working Group is deeply committed to this endeavour.
|